NCT01777412 Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO Exacerbations Status COMPLETED Phase PHASE1
NCT01623076 The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders Status ACTIVE_NOT_RECRUITING Phase N/A